Description
Roger Pharma LIBIDRIN (Bremelanotide) is a peptide formulation containing Bremelanotide (PT-141), a synthetic melanocortin receptor agonist widely studied for its interaction with the central nervous system and melanocortin pathways. It is commonly researched for its potential role in sexual function, arousal mechanisms, and neuroendocrine signaling.
Each pack contains 5 vials, with 10 mg of Bremelanotide per vial, providing a total peptide content of 50 mg. Roger Pharma LIBIDRIN is supplied in a lyophilized format and is intended for research applications involving peptide science, neurobiology, and melanocortin receptor studies.
Key Features
- Bremelanotide (PT-141) peptide formulation
- 10 mg per vial
- 5 vials per pack
- Total peptide content: 50 mg
- Lyophilized peptide format
- Studied for melanocortin receptor and neuroendocrine pathways
- Research-focused peptide compound
Contents
- Active Ingredient: Bremelanotide (PT-141) – 10 mg
- Quantity: 5 Vials
Reviews
There are no reviews yet.